The information within this section of the website is intended for UK Healthcare Professionals. UK Practice Managers should follow the relevant links.

Sit down, sit back, relax

This is your Prostap DCS comfort zone. A site where you can learn about Prostap DCS, explore the injection and its safety device in detail and order materials to help you support your endometriosis patients.

Contact

If you are a healthcare professional and have a clinical query about Prostap DCS, please call Medical Information on:

01628 537 900

If you would like to find out more about how Prostap DCS can help your practice save money, or to order, please call CLARITYpharma on:

0845 080 5190

If you are a healthcare professional and would like to be contacted about Prostap DCS, please enter your details in the short form below

Your Name
Email
Phone
Definition of Role
Practice address
Postcode
*Required fields

Takeda UK Ltd will NOT share any of your details with any other parties. If at any time you wish to unsubscribe from receiving information about Prostap DCS, please call Takeda UK Ltd on 01628 537 900.

References

  1. Takeda UK Ltd. Data on file, DF120604(2).
  2. Crosignani PG et al. Hum Reprod 1996;11:2732-35.
  3. Prostap SR DCS. Summary of Product Characteristics.
  4. Prostap 3 DCS. Summary of Product Characteristics.
  5. Health and Safety Executive. Health and Safety (Sharp Instruments in Healthcare) Regulations 2013. Available via: hse.gov.uk/pubns/hsis7.pdf (last accessed April 2018).
  6. European Agency for Safety and Health at Work. Directive 2010/32/EU – prevention from sharp injuries in the hospital and healthcare sector. Available via https://osha.europa.eu/en/legislation/directives/council-directive-2010-32-eu-prevention-from-sharp-injuries-in-the-hospital-and-healthcare-sector (last accessed April 2018).
  7. Ogawa Y et al. J Pharm 1989;41(7):439-44.
  8. Abouelfadel Z & Crawford D. Therapeut Clin Risk Manag 2008;4(2):513-26.
  9. The Leuprolide Study Group. N Eng J Med 1984;311:1281-6.
  10. Friedman AJ et al. Fertil Steril 1987;48(4):560-4.
  11. PharmaTimes online. Takeda launches new presentation of Prostap, 2011.
    Available via:
    http://www.pharmatimes.com/news/takeda_launches_new_presentation_of_prostap_980760 (last accessed April 2018).
  12. National Institute for Health and Care Excellence (2014) Prostate cancer: diagnosis and management. NICE guideline (CG175).

This part of the Prostap® DCS (leuprorelin acetate) online resource is specifically for Practice Managers.

If you are not a Practice Manager, please select the appropriate area of this website from the welcome page.

No

I am not a
Practice Manager

Yes

I am a
Practice Manager

This part of the Prostap® DCS (leuprorelin acetate) online resource is specifically for Healthcare Professionals.

If you are not a Healthcare Professional, please select NO to go back and select the appropriate section of this website for you.

No

I am not a Healthcare Professional

Yes

I am a Healthcare Professional interested in prostate cancer

Yes

I am a Healthcare Professional interested in endometriosis

This part of the Prostap® DCS (leuprorelin acetate) online resource is specifically for patients who have been prescribed Prostap DCS.

If you are not a patient who has been prescribed Prostap DCS, please select the appropriate area of this website from the welcome page.

No

I am not a Prostap DCS prescribed patient.

Yes

I am a Prostap DCS prescribed patient.